Do you want to read an article? Please log in or register.
Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study
Helicobacter Pylori
Related content
Helicobacter Pylori
Real-Time PCR Helicobacter pylori Test in Comparison With Culture and Histology for Helicobacter pylori Detection and Identification of Resistance to Clarithromycin: A Single-Center Real-Life Study
Helicobacter
Priadko K, Gibaud SA, Druet A, Galmiche L, Megraud F, Corvec S, Matysiak-Budnik T
doi: 10.1111/hel.70031
Helicobacter Pylori
Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
Helicobacter
Cheung KS, Lyu T, Deng Z, Han S, Ni L, Wu J, Tan JT, Qin J, Ng HY, Leung WK, Seto WK
doi: 10.1111/hel.13133
Helicobacter Pylori
Efficacy of Tegoprazan-Containing Sequential Eradication Treatment Compared to Esomeprazole-Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance: A Prospective, Randomized, Single Tertiary Center Study
Helicobacter
Lee JW, Kim N, Lee J, Jo SY, Lee DH
doi: 10.1111/hel.13143
Gastrointestinal CancerHelicobacter Pylori
Helicobacter pylori Eradication Therapy and the Risk of Colorectal Cancer: A Population-Based Nationwide Cohort Study in Sweden
Helicobacter
Liu Q, Sadr-Azodi O, Engstrand L, Fall K, Brusselaers N
doi: 10.1111/hel.70001
Inflammatory Bowel Disease
Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study
J Crohns Colitis
Zhao M, Larsen L, Dige A, Poulsen A, Lo B, Attauabi M, Dige Ovesen P, Wewer MD, Christiansen D, Hvas CL, Petersen AM, Bendtsen F, Seidelin J, Burisch J
doi: 10.1093/ecco-jcc/jjae192
Gastrointestinal CancerHelicobacter Pylori
Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies
Gastroenterology
Ford AC, Yuan Y, Park JY, Forman D, Moayyedi P
doi: 10.1053/j.gastro.2024.12.033
RECOMMENDED
Helicobacter Pylori
PROBIOTICS PRESCRIBED WITH HELICOBACTER PYLORI ERADICATION THERAPY IN EUROPE: USAGE PATTERN, EFFECTIVENESS, AND SAFETY: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg)
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Deza DC, Alcedo J, Lafuente M, López FJ, Perez-Aisa Á, Pavoni M, Tepes B, Jonaitis L, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Voynovan I, Bujanda L, Lucendo AJ, Jurecic NB, Denkovski M, Vologzanina L, Rodrigo L, Martínez-Domínguez SJ, Fadieienko G, Huguet JM, Abdulkhakov R, Abdulkhakov SR, Alcaide N, Velayos B, Hernández L, Bordin DS, Gasbarrini A, Kupcinskas J, Babayeva G, Gridnyev O, Leja M, Rokkas T, Marcos-Pinto R, Lerang F, Boltin D, Mestrovic A, Smith SM, Venerito M, Boyanova L, Milivojevic V, Doulberis M, Kunovsky L, Parra P, Cano-Català A, Moreira L, Nyssen OP, Megraud F, Morain CO, Gisbert JP, Hp-EuReg investigators
doi: 10.14309/ajg.0000000000003351
Helicobacter Pylori
Optimal Duration of Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis
Helicobacter
Duan M, Kong Q, Wang H, Li Y
doi: 10.1111/hel.13144
Helicobacter Pylori
Self-Correcting Method for Highly Effective Office-Based Helicobacter pylori Therapy Using Cumulative Test of Cure Data
Helicobacter
Dore MP, Hernaez R, Graham DY
doi: 10.1111/hel.13112